Editas Medicine
EDIT
230 hedge funds and large institutions have $188M invested in Editas Medicine in 2024 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 68 increasing their positions, 64 reducing their positions, and 41 closing their positions.
32% more call options, than puts
Call options by funds: $1.5M | Put options by funds: $1.14M
6% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 64
1.81% less ownership
Funds ownership: 68.57% → 66.76% (-1.8%)
3% less funds holding
Funds holding: 236 → 230 (-6)
12% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 41
29% less capital invested
Capital invested by funds: $263M → $188M (-$75.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$3.88M |
| 2 |
Two Sigma Investments
New York
|
+$3.56M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$2.83M |
| 4 |
Jane Street
New York
|
+$2.5M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$2.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$9.27M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$5.89M |
| 3 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$4.79M |
| 4 |
IHAM
Integral Health Asset Management
New York
|
-$3.15M |
| 5 |
Squarepoint
New York
|
-$2.62M |
EDIT Hedge Fund Activity: Q3 2024 in Review
230 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q3 2024, worth a combined $188M — down 29% from $263M a quarter earlier.
Sellers outnumbered buyers: 41 funds closed out of EDIT and 36 opened new positions — a net loss of 5 holders — while 64 trimmed existing stakes and 68 added.
The largest buyer was Millennium Management, adding an estimated $3.88M. The largest seller was State Street, cutting an estimated $9.27M.
- 230 institutional investors held Editas Medicine (EDIT) as of Q3 2024, down from 236 in Q2 2024.
- Funds reported $188M of Editas Medicine stock for Q3 2024, down 29% quarter-over-quarter.
- 36 funds opened new Editas Medicine positions in Q3 2024 and 41 closed out, a net change of -5 holders.
- The largest Editas Medicine buyer in Q3 2024 was Millennium Management, an estimated $3.88M added.
- The largest Editas Medicine seller in Q3 2024 was State Street, an estimated $9.27M sold.
Based on aggregated 13F filings for Q3 2024.